BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 31384818)

  • 1. In silico design and synthesis of targeted rutin derivatives as xanthine oxidase inhibitors.
    Malik N; Dhiman P; Khatkar A
    BMC Chem; 2019 Dec; 13(1):71. PubMed ID: 31384818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In silico design and synthesis of hesperitin derivatives as new xanthine oxidase inhibitors.
    Malik N; Dhiman P; Khatkar A
    BMC Chem; 2019 Dec; 13(1):53. PubMed ID: 31384801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanistic approach towards interaction of newly synthesized Hesperidin derivatives against xanthine oxidase.
    Malik N; Dhiman P; Khatkar A
    Int J Biol Macromol; 2019 Aug; 135():864-876. PubMed ID: 31163243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Computational Analysis and Synthesis of Syringic Acid Derivatives as Xanthine Oxidase Inhibitors.
    Malik N; Khatkar A; Dhiman P
    Med Chem; 2020; 16(5):643-653. PubMed ID: 31584375
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Malik N; Dhiman P; Khatkar A
    Curr Drug Targets; 2019; 20(5):593-603. PubMed ID: 30465499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-gout activity and the interaction mechanisms between Sanghuangporus vaninii active components and xanthine oxidase.
    Song J; Wang Z; Chi Y; Zhang Y; Fang C; Shu Y; Cui J; Bai H; Wang J
    Bioorg Chem; 2023 Apr; 133():106394. PubMed ID: 36801789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Xanthine oxidase inhibitory activity of nicotino/isonicotinohydrazides: A systematic approach from in vitro, in silico to in vivo studies.
    Zafar H; Hayat M; Saied S; Khan M; Salar U; Malik R; Choudhary MI; Khan KM
    Bioorg Med Chem; 2017 Apr; 25(8):2351-2371. PubMed ID: 28302506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and evaluation of xanthine oxidase inhibitory and antioxidant activities of 2-arylbenzo[b]furan derivatives based on salvianolic acid C.
    Tang HJ; Zhang XW; Yang L; Li W; Li JH; Wang JX; Chen J
    Eur J Med Chem; 2016 Nov; 124():637-648. PubMed ID: 27614410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, synthesis, biological evaluation of 3,5-diaryl-4,5-dihydro-1H-pyrazole carbaldehydes as non-purine xanthine oxidase inhibitors: Tracing the anticancer mechanism via xanthine oxidase inhibition.
    Joshi G; Sharma M; Kalra S; Gavande NS; Singh S; Kumar R
    Bioorg Chem; 2021 Feb; 107():104620. PubMed ID: 33454509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis, structure-activity relationships, and mechanistic studies of 5-arylazo-tropolone derivatives as novel xanthine oxidase (XO) inhibitors.
    Sato D; Kisen T; Kumagai M; Ohta K
    Bioorg Med Chem; 2018 Jan; 26(2):536-542. PubMed ID: 29274704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and evaluation of hydroxychalcones as multifunctional non-purine xanthine oxidase inhibitors for the treatment of hyperuricemia.
    Xie Z; Luo X; Zou Z; Zhang X; Huang F; Li R; Liao S; Liu Y
    Bioorg Med Chem Lett; 2017 Aug; 27(15):3602-3606. PubMed ID: 28655421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis and biological evaluation of novel xanthine oxidase inhibitors bearing a 2-arylbenzo[b]furan scaffold.
    Tang HJ; Li W; Zhou M; Peng LY; Wang JX; Li JH; Chen J
    Eur J Med Chem; 2018 May; 151():849-860. PubMed ID: 29684895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Xanthine Oxidase Inhibitory and Molecular Docking Studies on Pyrimidones.
    Zafar H; Iqbal S; Javaid S; Khan KM; Choudhary MI
    Med Chem; 2018; 14(5):524-535. PubMed ID: 29189174
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Mehmood A; Rehman AU; Ishaq M; Zhao L; Li J; Usman M; Zhao L; Rehman A; Zad OD; Wang C
    Comb Chem High Throughput Screen; 2020; 23(9):917-930. PubMed ID: 32342806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. S-allyl cysteine as potent anti-gout drug: Insight into the xanthine oxidase inhibition and anti-inflammatory activity.
    Johnson P; Loganathan C; Iruthayaraj A; Poomani K; Thayumanavan P
    Biochimie; 2018 Nov; 154():1-9. PubMed ID: 30059711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design and synthesis of chalcone derivatives as potential non-purine xanthine oxidase inhibitors.
    Bui TH; Nguyen NT; Dang PH; Nguyen HX; Nguyen MT
    Springerplus; 2016; 5(1):1789. PubMed ID: 27795931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and Biological Evaluation of Novel Aryl-2H-pyrazole Derivatives as Potent Non-purine Xanthine Oxidase Inhibitors.
    Sun ZG; Zhou XJ; Zhu ML; Ding WZ; Li Z; Zhu HL
    Chem Pharm Bull (Tokyo); 2015; 63(8):603-7. PubMed ID: 26040271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In-silico Design and ADMET Studies of Natural Compounds as Inhibitors of Xanthine Oxidase (XO) Enzyme.
    Malik N; Dhiman P; Khatkar A
    Curr Drug Metab; 2017; 18(6):577-593. PubMed ID: 28302027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In Silico and 3D QSAR Studies of Natural Based Derivatives as Xanthine Oxidase Inhibitors.
    Malik N; Dhiman P; Khatkar A
    Curr Top Med Chem; 2019; 19(2):123-138. PubMed ID: 30727896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and biological evaluation of 2-(4-alkoxy-3-cyano)phenylpyrimidine derivatives with 4-amino or 4-hydroxy as a pharmacophore element binding with xanthine oxidase active site.
    Sun M; Zhao J; Mao Q; Yan C; Zhang B; Yang Y; Dai X; Gao J; Lin F; Duan Y; Zhang T; Wang S
    Bioorg Med Chem; 2021 May; 38():116117. PubMed ID: 33838610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.